Cantor Fitzgerald Reaffirms “Overweight” Rating for Elevance Health (NYSE:ELV)

Elevance Health (NYSE:ELVGet Free Report)‘s stock had its “overweight” rating reaffirmed by equities research analysts at Cantor Fitzgerald in a research report issued on Friday,Benzinga reports. They currently have a $485.00 target price on the stock. Cantor Fitzgerald’s price target indicates a potential upside of 20.82% from the stock’s current price. Cantor Fitzgerald also issued estimates for Elevance Health’s FY2025 earnings at $34.57 EPS.

Several other equities analysts have also recently weighed in on ELV. Mizuho cut their price objective on Elevance Health from $585.00 to $505.00 and set an “outperform” rating for the company in a research report on Tuesday, November 5th. Argus lowered Elevance Health from a “buy” rating to a “hold” rating in a report on Friday, October 18th. StockNews.com upgraded shares of Elevance Health from a “hold” rating to a “buy” rating in a research note on Friday, January 17th. TD Cowen cut their target price on shares of Elevance Health from $589.00 to $484.00 and set a “buy” rating for the company in a research note on Monday, October 21st. Finally, Wells Fargo & Company decreased their price target on shares of Elevance Health from $593.00 to $495.00 and set an “overweight” rating on the stock in a research report on Monday, November 4th. Three equities research analysts have rated the stock with a hold rating, thirteen have issued a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $525.60.

View Our Latest Analysis on ELV

Elevance Health Stock Up 0.0 %

Shares of Elevance Health stock opened at $401.43 on Friday. Elevance Health has a 12-month low of $362.21 and a 12-month high of $567.26. The stock has a market capitalization of $93.10 billion, a P/E ratio of 14.63, a PEG ratio of 1.11 and a beta of 0.84. The company has a quick ratio of 1.50, a current ratio of 1.50 and a debt-to-equity ratio of 0.56. The stock has a 50 day moving average price of $386.21 and a two-hundred day moving average price of $462.34.

Elevance Health (NYSE:ELVGet Free Report) last posted its quarterly earnings data on Thursday, January 23rd. The company reported $3.84 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.80 by $0.04. Elevance Health had a net margin of 3.68% and a return on equity of 19.56%. Equities analysts expect that Elevance Health will post 32.95 earnings per share for the current year.

Institutional Trading of Elevance Health

Large investors have recently bought and sold shares of the stock. Calamos Advisors LLC boosted its stake in shares of Elevance Health by 0.5% in the 4th quarter. Calamos Advisors LLC now owns 24,774 shares of the company’s stock valued at $9,139,000 after purchasing an additional 131 shares in the last quarter. Childress Capital Advisors LLC boosted its position in Elevance Health by 13.8% in the fourth quarter. Childress Capital Advisors LLC now owns 691 shares of the company’s stock valued at $255,000 after buying an additional 84 shares in the last quarter. JB Capital LLC grew its stake in Elevance Health by 597.2% during the fourth quarter. JB Capital LLC now owns 9,384 shares of the company’s stock worth $3,462,000 after buying an additional 8,038 shares during the last quarter. Chicago Capital LLC increased its holdings in shares of Elevance Health by 7.2% during the fourth quarter. Chicago Capital LLC now owns 2,169 shares of the company’s stock worth $800,000 after buying an additional 145 shares in the last quarter. Finally, Oregon Pacific Wealth Management LLC bought a new position in shares of Elevance Health in the fourth quarter valued at approximately $532,000. 89.24% of the stock is currently owned by institutional investors.

Elevance Health Company Profile

(Get Free Report)

Elevance Health, Inc, together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits.

Further Reading

Analyst Recommendations for Elevance Health (NYSE:ELV)

Receive News & Ratings for Elevance Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elevance Health and related companies with MarketBeat.com's FREE daily email newsletter.